1201 - 1250 of 7939 Results
Title
Year
-
RESTRICTEDTitle: Somatic CNV Detection by Single-Cell Whole-Genome Sequencing in Postmortem Human BrainJournal Name: Methods in Molecular BiologyPublisher: Springer USVol:Issue #:Start Page: 205End Page: 230Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-0716-2655-9_11Citation Count: 3
- Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy2022RESTRICTEDTitle: Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment StrategyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 14340End Page: 14340Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232214340Best OA location URL: https://www.mdpi.com/1422-0067/23/22/14340/pdf?version=1669106553Citation Count: 8
- BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's disease2022OPENTitle: BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1053591Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.1053591/pdfCitation Count: 0
- Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome2022OPENTitle: Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisomeJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-01113-5Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-022-01113-5Citation Count: 65
- Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive decline2022OPENTitle: Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive declineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 106Issue #:Start Page: 105221End Page: 105221Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.11.013Best OA location URL: http://www.prd-journal.com/article/S1353802022003819/pdfCitation Count: 3
-
RESTRICTEDTitle: Major advances in Parkinson's disease over the past two decades and future research directionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1076End Page: 1079Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00448-3Citation Count: 9
-
RESTRICTEDTitle: Revisiting levodopa for advanced Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1063End Page: 1065Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00435-5Citation Count: 1
- Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial2022RESTRICTEDTitle: Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1099End Page: 1109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00400-8Citation Count: 49
-
OPENTitle: Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammationJournal Name: Genome MedicinePublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13073-022-01132-9Best OA location URL: https://genomemedicine.biomedcentral.com/counter/pdf/10.1186/s13073-022-01132-9Citation Count: 8
-
RESTRICTEDTitle: Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s DiseaseJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 12Start Page: 1249End Page: 1267Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-022-00973-7Citation Count: 5
- Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms2022OPENTitle: Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanismsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-34667-xBest OA location URL: https://www.nature.com/articles/s41467-022-34667-x.pdfCitation Count: 126
- Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson’s Disease2022OPENTitle: Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 14018End Page: 14018Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232214018Best OA location URL: https://www.mdpi.com/1422-0067/23/22/14018/pdf?version=1668398534Citation Count: 9
-
RESTRICTEDTitle: Genotype–Phenotype Correlations for ATX‐TBP (SCA17): MDSGene Systematic ReviewJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 3Start Page: 368End Page: 377Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29278Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29278Citation Count: 7
-
OPENTitle: Movement Disorders andSARS‐CoV‐2Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13615Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448146Citation Count: 3
- APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s disease2022OPENTitle: APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00411-xBest OA location URL: https://www.nature.com/articles/s41531-022-00411-x.pdfCitation Count: 6
- Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson’s Disease2022OPENTitle: Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 13985End Page: 13985Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232213985Best OA location URL: https://www.mdpi.com/1422-0067/23/22/13985/pdf?version=1668767894Citation Count: 8
- Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's disease2022OPENTitle: Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 177Issue #:Start Page: 108419End Page: 108419Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108419Best OA location URL: https://doi.org/10.1016/j.neuropsychologia.2022.108419Citation Count: 8
- Digitizing a Therapeutic: Development of an Augmented Reality Dual-Task Training Platform for Parkinson’s Disease2022OPENTitle: Digitizing a Therapeutic: Development of an Augmented Reality Dual-Task Training Platform for Parkinson’s DiseaseJournal Name: SensorsPublisher: MDPI AGVol: 22Issue #: 22Start Page: 8756End Page: 8756Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s22228756Best OA location URL: https://www.mdpi.com/1424-8220/22/22/8756/pdf?version=1668248220Citation Count: 5
-
OPENTitle: Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s diseaseJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-01116-2Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-022-01116-2Citation Count: 25
- Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders2022OPENTitle: Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disordersJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01468-8Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-022-01468-8Citation Count: 36
- Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose2022OPENTitle: Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene doseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 5Start Page: 2095End Page: 2116Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12835Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12835Citation Count: 9
- Compensation Strategies for Gait Impairments in Parkinson's Disease: From Underlying Mechanisms to Daily Clinical Practice2022OPENTitle: Compensation Strategies for Gait Impairments in Parkinson's Disease: From Underlying Mechanisms to Daily Clinical PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13616Best OA location URL: https://doi.org/10.1002/mdc3.13616Citation Count: 4
-
RESTRICTEDTitle: GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 5Start Page: 1859End Page: 1872Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac413Best OA location URL: https://academic.oup.com/brain/article-pdf/146/5/1859/50127735/awac413.pdfCitation Count: 11
-
OPENTitle: The Existential Essentialism in Tremor Nosology − 7 Pitfalls, 2 Remedies, and a Path AheadJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13622Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448133Citation Count: 3
- CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkers2022OPENTitle: CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkersJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 94Issue #: 3Start Page: 211End Page: 219Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2022-330052Best OA location URL: https://jnnp.bmj.com/content/jnnp/94/3/211.full.pdfCitation Count: 7
- Epidemiology meets toxicogenomics: Mining toxicologic evidence in support of an untargeted analysis of pesticides exposure and Parkinson’s disease2022OPENTitle: Epidemiology meets toxicogenomics: Mining toxicologic evidence in support of an untargeted analysis of pesticides exposure and Parkinson’s diseaseJournal Name: Environment InternationalPublisher: Elsevier BVVol: 170Issue #:Start Page: 107613End Page: 107613Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.envint.2022.107613Best OA location URL: https://doi.org/10.1016/j.envint.2022.107613Citation Count: 8
- Older patients with COVID‐19 and neuropsychiatric conditions: A study of risk factors for mortality2022OPENTitle: Older patients with COVID‐19 and neuropsychiatric conditions: A study of risk factors for mortalityJournal Name: Brain and BehaviorPublisher: WileyVol: 12Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2787Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.2787Citation Count: 1
- R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations2022OPENTitle: R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterationsJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-04136-8Best OA location URL: https://www.nature.com/articles/s42003-022-04136-8.pdfCitation Count: 8
-
OPENTitle: Stability of motor-nonmotor subtype in early-stage Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1040405Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1040405/pdfCitation Count: 2
- The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program2022OPENTitle: The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1036068Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.1036068/pdfCitation Count: 16
-
RESTRICTEDTitle: Association between theLRP1BandAPOEloci and the development of Parkinson’s disease dementiaJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 5Start Page: 1873End Page: 1887Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac414Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awac414/49099551/awac414.pdfCitation Count: 19
-
RESTRICTEDTitle: Genome-wide contribution of common short-tandem repeats to Parkinson’s disease genetic riskJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 1Start Page: 65End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awac301Best OA location URL: https://academic.oup.com/brain/article-pdf/146/1/65/49693430/awac301.pdfCitation Count: 15
- Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and Differentiation2022RESTRICTEDTitle: Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and DifferentiationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 23Start Page: 3281End Page: 3290Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00342Citation Count: 10
- A prebiotic diet modulates microglial states and motor deficits in α-synuclein overexpressing mice2022OPENTitle: A prebiotic diet modulates microglial states and motor deficits in α-synuclein overexpressing miceJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.81453Best OA location URL: https://doi.org/10.7554/elife.81453Citation Count: 32
- Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease2022RESTRICTEDTitle: Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 13678End Page: 13678Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232213678Best OA location URL: https://www.mdpi.com/1422-0067/23/22/13678/pdf?version=1668567593Citation Count: 6
-
OPENTitle: Mitochondrial haplogroups and cognitive progression in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 1Start Page: 42End Page: 49Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac327Best OA location URL: https://scholarlypublications.universiteitleiden.nl/access/item%3A3635302/viewCitation Count: 5
-
OPENTitle: A connectomics-based taxonomy of mammalsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.78635Best OA location URL: https://doi.org/10.7554/elife.78635Citation Count: 19
-
OPENTitle: Bootstrap-adjusted quasi-likelihood information criteria for mixed model selectionJournal Name: Journal of Applied StatisticsPublisher: Informa UK LimitedVol: 51Issue #: 4Start Page: 621End Page: 645Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/02664763.2022.2143484Best OA location URL: https://etd.ohiolink.edu/acprod/odb_etd/ws/send_file/send?accession=bgsu156207676645628&disposition=inlineCitation Count: 3
-
OPENTitle: Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00409-5Best OA location URL: https://www.nature.com/articles/s41531-022-00409-5.pdfCitation Count: 17
-
RESTRICTEDTitle: Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled TrialJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 201End Page: 211Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29268Citation Count: 24
- Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia2022OPENTitle: Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementiaJournal Name: Human Brain MappingPublisher: WileyVol: 44Issue #: 3Start Page: 1079End Page: 1093Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/hbm.26140Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875921Citation Count: 7
-
RESTRICTEDTitle: Home Wireless Device Tracks Body Movements in People with Parkinson's DiseaseJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 22Issue #: 21Start Page: 6End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000899540.26889.fcCitation Count: 1
-
OPENTitle: Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicityJournal Name: Brain PathologyPublisher: WileyVol: 33Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/bpa.13130Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bpa.13130Citation Count: 2
-
OPENTitle: Progression of regional cortical cholinergic denervation in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/braincomms/fcac320Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772878Citation Count: 14
-
OPENTitle: Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2, Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 174Issue #:Start Page: 105885End Page: 105885Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105885Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105885Citation Count: 6
-
OPENTitle: Decreased Water Mobility Contributes To Increased α‐Synuclein Aggregation**Journal Name: Angewandte ChemiePublisher: WileyVol: 135Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/ange.202212063Best OA location URL: https://doi.org/10.1002/ange.202212063Citation Count: 2
-
OPENTitle: Decreased Water Mobility Contributes To Increased α‐Synuclein Aggregation**Journal Name: Angewandte Chemie International EditionPublisher: WileyVol: 62Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/anie.202212063Best OA location URL: https://doi.org/10.1002/anie.202212063Citation Count: 10
-
OPENTitle: Longitudinal Clinical and Biological Characteristics in Juvenile‐Onset Huntington's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 1Start Page: 113End Page: 122Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29251Citation Count: 5
-
RESTRICTEDTitle: Tracer development for PET imaging of proteinopathiesJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 114-115Issue #:Start Page: 115End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nucmedbio.2022.04.001Best OA location URL: https://doi.org/10.1016/j.nucmedbio.2022.04.001Citation Count: 3
-
RESTRICTEDTitle: Diagnosis and Management of Functional Tic-Like PhenomenaJournal Name: Journal of Clinical MedicinePublisher: MDPI AGVol: 11Issue #: 21Start Page: 6470End Page: 6470Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/jcm11216470Best OA location URL: https://www.mdpi.com/2077-0383/11/21/6470/pdf?version=1667888847Citation Count: 17